LivaNova PLC
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 1.04B | 1.02B | 1.15B | 1.25B | 1.39B | 10.7% | |
| Cost of Revenue | (329.37M) | (314.58M) | (382.30M) | (382.56M) | (448.20M) | 17.2% | |
Gross Profit | 705.99M | 707.23M | 771.25M | 870.87M | 939.90M | 7.9% | |
| Operating Expenses | |||||||
| Research & Development | (183.41M) | (155.81M) | (193.82M) | (182.51M) | (185.80M) | 1.8% | |
| Selling, General & Administrative | (471.90M) | (469.24M) | (518.13M) | (526.26M) | (548.80M) | 4.3% | |
| Depreciation & Amortization | (67.99M) | (57.80M) | (60.86M) | (51.14M) | (42.00M) | -17.9% | |
Operating Income (EBIT) | -784.00K | -76.75M | -68.50M | 129.05M | 199.40M | 54.5% | |
| Non-Operating Items | |||||||
| Interest Income | 435.00K | 4.70M | 22.01M | 30.07M | 18.98M | -36.9% | |
| Interest Expense | (50.15M) | (48.25M) | (58.85M) | (63.07M) | (49.29M) | -21.9% | |
| Other Income/Expenses (Net) | -123.84M | 1.56M | -12.83M | -40.74M | -420.20M | 931.4% | |
Income Before Tax | -124.62M | -75.19M | -81.33M | 88.31M | -220.80M | -350.0% | |
| Income Tax Expense | (11.20M) | (11.05M) | (98.88M) | (25.06M) | (21.60M) | -13.8% | |
Net Income | -135.82M | -86.25M | 17.55M | 63.23M | -242.50M | -483.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-3 | $-2 | $0 | $1 | $-4 | -480.3% | |
| Weighted Avg Shares Outstanding | 50.63M | 53.50M | 53.90M | 54.24M | 54.50M | 0.5% | |
| Weighted Avg Shares Outstanding (Diluted) | 50.63M | 53.50M | 54.21M | 54.57M | 54.50M | -0.1% | |
EBITDA | -6.33M | 30.90M | 38.48M | 202.52M | -129.50M | -163.9% |
Explore LIVN
LIVN in the Healthcare
Mid Cap